KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Receivables: 2009-2025

Historic Receivables for Thermo Fisher Scientific (TMO) over the last 17 years, with Sep 2025 value amounting to $10.5 billion.

  • Thermo Fisher Scientific's Receivables rose 7.50% to $10.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $40.0 billion, marking a year-over-year increase of 4.63%. This contributed to the annual value of $9.6 billion for FY2024, which is 0.39% down from last year.
  • Latest data reveals that Thermo Fisher Scientific reported Receivables of $10.5 billion as of Q3 2025, which was up 4.94% from $10.0 billion recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Receivables ranged from a high of $10.5 billion in Q3 2025 and a low of $6.3 billion during Q3 2021.
  • Over the past 3 years, Thermo Fisher Scientific's median Receivables value was $9.7 billion (recorded in 2023), while the average stood at $9.7 billion.
  • As far as peak fluctuations go, Thermo Fisher Scientific's Receivables surged by 41.59% in 2022, and later fell by 0.59% in 2024.
  • Quarterly analysis of 5 years shows Thermo Fisher Scientific's Receivables stood at $8.9 billion in 2021, then grew by 5.39% to $9.4 billion in 2022, then climbed by 2.51% to $9.7 billion in 2023, then declined by 0.39% to $9.6 billion in 2024, then rose by 7.50% to $10.5 billion in 2025.
  • Its Receivables was $10.5 billion in Q3 2025, compared to $10.0 billion in Q2 2025 and $9.8 billion in Q1 2025.